|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1201 to 1300 out of 2905 for Actb

0.016s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication  
First Author: Fabian A
Year: 2019
Journal: Cancer Lett
Title: Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells.
Volume: 453
Pages: 95-106
Publication
First Author: Jiang SH
Year: 2017
Journal: Gastroenterology
Title: Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Volume: 153
Issue: 1
Pages: 277-291.e19
Publication  
First Author: Chen X
Year: 2017
Journal: Cancer Lett
Title: Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.
Volume: 399
Pages: 20-28
Publication
First Author: D'Costa Z
Year: 2017
Journal: Cancer Res
Title: Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer.
Volume: 77
Issue: 21
Pages: 5952-5962
Publication
First Author: Cao XY
Year: 2018
Journal: Biochem Biophys Res Commun
Title: Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Volume: 499
Issue: 3
Pages: 584-593
Publication
First Author: He D
Year: 2022
Journal: Mol Cell
Title: Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis.
Volume: 82
Issue: 16
Pages: 3045-3060.e11
Publication
First Author: Flint TR
Year: 2016
Journal: Cell Metab
Title: Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.
Volume: 24
Issue: 5
Pages: 672-684
Publication
First Author: Greco SH
Year: 2015
Journal: PLoS One
Title: TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
Volume: 10
Issue: 7
Pages: e0132786
Publication
First Author: Sainz B Jr
Year: 2014
Journal: Cancer Res
Title: ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.
Volume: 74
Issue: 24
Pages: 7309-20
Publication
First Author: Olive KP
Year: 2009
Journal: Science
Title: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
Volume: 324
Issue: 5933
Pages: 1457-61
Publication
First Author: Fendrich V
Year: 2011
Journal: Neoplasia
Title: Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
Volume: 13
Issue: 2
Pages: 180-6
Publication
First Author: He F
Year: 2023
Journal: Cancer Res
Title: FPR2 Shapes an Immune-Excluded Pancreatic Tumor Microenvironment and Drives T-cell Exhaustion in a Sex-Dependent Manner.
Volume: 83
Issue: 10
Pages: 1628-1645
Publication
First Author: Wasylishen AR
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress.
Volume: 117
Issue: 12
Pages: 6622-6629
Publication
First Author: Shields DJ
Year: 2011
Journal: Oncogene
Title: Oncogenic Ras/Src cooperativity in pancreatic neoplasia.
Volume: 30
Issue: 18
Pages: 2123-34
Publication
First Author: Palm W
Year: 2015
Journal: Cell
Title: The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1.
Volume: 162
Issue: 2
Pages: 259-270
Publication
First Author: Roe JS
Year: 2017
Journal: Cell
Title: Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.
Volume: 170
Issue: 5
Pages: 875-888.e20
Publication  
First Author: Jiang SH
Year: 2022
Journal: EBioMedicine
Title: Modeling of cancer-related body-wide effects identifies LTB4 as a diagnostic biomarker for pancreatic cancer.
Volume: 80
Pages: 104050
Publication
First Author: Kersemans V
Year: 2017
Journal: PLoS One
Title: An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouse.
Volume: 12
Issue: 4
Pages: e0176693
Publication
First Author: Baird JR
Year: 2017
Journal: PLoS One
Title: STING expression and response to treatment with STING ligands in premalignant and malignant disease.
Volume: 12
Issue: 11
Pages: e0187532
Publication
First Author: Gao C
Year: 2019
Journal: Cell Mol Gastroenterol Hepatol
Title: PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-CateninY654.
Volume: 8
Issue: 4
Pages: 561-578
Publication
First Author: Strand MS
Year: 2019
Journal: Oncotarget
Title: Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles.
Volume: 10
Issue: 46
Pages: 4761-4775
Publication
First Author: Shields MA
Year: 2022
Journal: Cell Rep
Title: Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin.
Volume: 38
Issue: 9
Pages: 110441
Publication
First Author: Husain K
Year: 2013
Journal: Cancer Prev Res (Phila)
Title: Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.
Volume: 6
Issue: 10
Pages: 1074-83
Publication
First Author: Grünwald B
Year: 2016
Journal: Mol Cancer Res
Title: Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow.
Volume: 14
Issue: 11
Pages: 1147-1158
Publication
First Author: Kühnemuth B
Year: 2015
Journal: Oncogene
Title: CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling.
Volume: 34
Issue: 2
Pages: 177-87
Publication  
First Author: Li C
Year: 2019
Journal: Front Physiol
Title: MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).
Volume: 10
Pages: 147
Publication
First Author: Jacobson R
Year: 2024
Journal: Sci Rep
Title: Differential extracellular vesicle concentration and their biomarker expression of integrin α(v)/β(5), EpCAM, and glypican-1 in pancreatic cancer models.
Volume: 14
Issue: 1
Pages: 14273
Publication
First Author: Kaune T
Year: 2023
Journal: iScience
Title: Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer.
Volume: 26
Issue: 6
Pages: 106841
Publication
First Author: Jiang S
Year: 2017
Journal: Biochem Biophys Res Commun
Title: Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
Volume: 494
Issue: 1-2
Pages: 113-119
Publication
First Author: Shen R
Year: 2013
Journal: Cancer Lett
Title: The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Volume: 339
Issue: 1
Pages: 135-43
Publication
First Author: Li H
Year: 2013
Journal: Carcinogenesis
Title: Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
Volume: 34
Issue: 9
Pages: 2090-8
Publication
First Author: Maity G
Year: 2018
Journal: J Biol Chem
Title: The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Volume: 293
Issue: 12
Pages: 4334-4349
Publication
First Author: Pushalkar S
Year: 2018
Journal: Cancer Discov
Title: The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.
Volume: 8
Issue: 4
Pages: 403-416
Publication
First Author: Costamagna A
Year: 2022
Journal: Gastroenterology
Title: Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis.
Volume: 162
Issue: 4
Pages: 1242-1255.e11
Publication
First Author: Nimmakayala RK
Year: 2021
Journal: Oncogene
Title: Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Volume: 40
Issue: 1
Pages: 215-231
Publication  
First Author: Schneider P
Year: 2015
Journal: Nat Commun
Title: Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.
Volume: 6
Pages: 8023
Publication
First Author: Carapuça EF
Year: 2016
Journal: J Pathol
Title: Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma.
Volume: 239
Issue: 3
Pages: 286-96
Publication
First Author: Wang F
Year: 2020
Journal: Cancer Res
Title: p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis.
Volume: 80
Issue: 16
Pages: 3251-3264
Publication  
First Author: Rahn S
Year: 2018
Journal: Cancer Lett
Title: Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells.
Volume: 415
Pages: 129-150
Publication
First Author: Cook N
Year: 2012
Journal: J Exp Med
Title: Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma.
Volume: 209
Issue: 3
Pages: 437-44
Publication  
First Author: Natarajan V
Year: 2022
Journal: Cancers (Basel)
Title: Acquired αSMA Expression in Pericytes Coincides with Aberrant Vascular Structure and Function in Pancreatic Ductal Adenocarcinoma.
Volume: 14
Issue: 10
Publication
First Author: Yang J
Year: 2019
Journal: Am J Cancer Res
Title: Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.
Volume: 9
Issue: 11
Pages: 2456-2468
Publication
First Author: Ganguly K
Year: 2022
Journal: Gastroenterology
Title: Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity.
Volume: 162
Issue: 7
Pages: 2032-2046.e12
Publication
First Author: Mendez R
Year: 2020
Journal: Carcinogenesis
Title: Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.
Volume: 41
Issue: 5
Pages: 561-570
Publication  
First Author: Lee JW
Year: 2016
Journal: Curr Protoc Pharmacol
Title: Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.
Volume: 73
Pages: 14.39.1-14.39.20
Publication
First Author: Ferguson FM
Year: 2020
Journal: Nat Chem Biol
Title: Discovery of a selective inhibitor of doublecortin like kinase 1.
Volume: 16
Issue: 6
Pages: 635-643
Publication
First Author: Burrack AL
Year: 2019
Journal: Cell Rep
Title: Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma.
Volume: 28
Issue: 8
Pages: 2140-2155.e6
Publication
First Author: Fendrich V
Year: 2018
Journal: Oncogene
Title: Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
Volume: 37
Issue: 14
Pages: 1845-1856
Publication  
First Author: Garg B
Year: 2017
Journal: Cancer Lett
Title: Modulation of post-translational modifications in β-catenin and LRP6 inhibits Wnt signaling pathway in pancreatic cancer.
Volume: 388
Pages: 64-72
Publication
First Author: Chugh S
Year: 2018
Journal: Gastroenterology
Title: Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Volume: 155
Issue: 5
Pages: 1608-1624
Publication
First Author: Davidson SM
Year: 2017
Journal: Nat Med
Title: Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.
Volume: 23
Issue: 2
Pages: 235-241
Publication  
First Author: Verma RK
Year: 2016
Journal: Sci Rep
Title: α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
Volume: 6
Pages: 32743
Publication
First Author: Noguchi K
Year: 2018
Journal: Oncol Lett
Title: c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer.
Volume: 16
Issue: 2
Pages: 1892-1898
Publication
First Author: Boj SF
Year: 2015
Journal: Cell
Title: Organoid models of human and mouse ductal pancreatic cancer.
Volume: 160
Issue: 1-2
Pages: 324-38
Publication
First Author: Frese KK
Year: 2012
Journal: Cancer Discov
Title: nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.
Volume: 2
Issue: 3
Pages: 260-269
Publication
First Author: Dauer P
Year: 2018
Journal: Cancer Res
Title: Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.
Volume: 78
Issue: 5
Pages: 1321-1333
Publication
First Author: Miller BW
Year: 2015
Journal: EMBO Mol Med
Title: Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.
Volume: 7
Issue: 8
Pages: 1063-76
Publication
First Author: Lee JS
Year: 2021
Journal: Theranostics
Title: Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse.
Volume: 11
Issue: 7
Pages: 3472-3488
Publication
First Author: Ganguly K
Year: 2021
Journal: Cancer Res
Title: Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness.
Volume: 81
Issue: 1
Pages: 91-102
Publication
First Author: Ueda Y
Year: 2019
Journal: Oncotarget
Title: Application of C. elegans cancer screening test for the detection of pancreatic tumor in genetically engineered mice.
Volume: 10
Issue: 52
Pages: 5412-5418
Publication
First Author: Dugnani E
Year: 2018
Journal: Carcinogenesis
Title: Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound.
Volume: 39
Issue: 9
Pages: 1197-1206
Publication
First Author: Nagathihalli NS
Year: 2018
Journal: Cancer Res
Title: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Volume: 78
Issue: 21
Pages: 6235-6246
Publication  
First Author: Cortes E
Year: 2019
Journal: EMBO Rep
Title: GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment.
Volume: 20
Issue: 1
Publication
First Author: Parameswaran N
Year: 2019
Journal: Sci Rep
Title: A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas.
Volume: 9
Issue: 1
Pages: 13396
Publication
First Author: Filippini D
Year: 2019
Journal: Sci Rep
Title: Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease.
Volume: 9
Issue: 1
Pages: 12286
Publication
First Author: Xu D
Year: 2019
Journal: Mol Carcinog
Title: Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53.
Volume: 58
Issue: 11
Pages: 2052-2064
Publication
First Author: Hein AL
Year: 2016
Journal: Cancer Res
Title: PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling.
Volume: 76
Issue: 8
Pages: 2243-2253
Publication    
First Author: Sullivan MR
Year: 2019
Journal: Elife
Title: Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability.
Volume: 8
Publication
First Author: Lee JC
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
Volume: 440
Issue: 1
Pages: 50-5
Publication
First Author: Dey S
Year: 2020
Journal: Mol Cancer Res
Title: miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2.
Volume: 18
Issue: 2
Pages: 311-323
Publication
First Author: Chugh R
Year: 2012
Journal: Sci Transl Med
Title: A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
Volume: 4
Issue: 156
Pages: 156ra139
Publication
First Author: Okabe J
Year: 2023
Journal: J Exp Clin Cancer Res
Title: Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity.
Volume: 42
Issue: 1
Pages: 262
Publication
First Author: Leal AS
Year: 2016
Journal: Carcinogenesis
Title: The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer.
Volume: 37
Issue: 12
Pages: 1170-1179
Publication
First Author: Ganguly K
Year: 2022
Journal: Gastroenterology
Title: Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance.
Volume: 162
Issue: 1
Pages: 253-268.e13
Publication
First Author: Mayers JR
Year: 2014
Journal: Nat Med
Title: Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.
Volume: 20
Issue: 10
Pages: 1193-1198
Publication
First Author: Deng YZ
Year: 2018
Journal: J Exp Med
Title: Cilia loss sensitizes cells to transformation by activating the mevalonate pathway.
Volume: 215
Issue: 1
Pages: 177-195
Publication
First Author: Qiu W
Year: 2016
Journal: Gastroenterology
Title: Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Volume: 150
Issue: 1
Pages: 218-228.e12
Publication  
First Author: Cortez NE
Year: 2023
Journal: Int J Mol Sci
Title: A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice.
Volume: 24
Issue: 13
Publication
First Author: Novo D
Year: 2018
Journal: Nat Commun
Title: Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels.
Volume: 9
Issue: 1
Pages: 5069
Publication
First Author: Hu T
Year: 2021
Journal: Gastroenterology
Title: Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression.
Volume: 161
Issue: 5
Pages: 1584-1600
Publication
First Author: Li T
Year: 2015
Journal: Cancer Res
Title: Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer.
Volume: 75
Issue: 18
Pages: 3738-46
Publication
First Author: Ireland L
Year: 2016
Journal: Cancer Res
Title: Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.
Volume: 76
Issue: 23
Pages: 6851-6863
Publication
First Author: Daley D
Year: 2017
Journal: Nat Med
Title: Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.
Volume: 23
Issue: 5
Pages: 556-567
Publication      
First Author: Koni PA
Year: 2011
Journal: MGI Direct Data Submission
Title: Generation of a cre knock-in allele at the Cd8a locus
Publication
First Author: Wende H
Year: 2012
Journal: Science
Title: The transcription factor c-Maf controls touch receptor development and function.
Volume: 335
Issue: 6074
Pages: 1373-6
Publication
First Author: Cobb J
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: A mouse model for human short-stature syndromes identifies Shox2 as an upstream regulator of Runx2 during long-bone development.
Volume: 103
Issue: 12
Pages: 4511-5
Publication
First Author: Lim ST
Year: 2010
Journal: J Biol Chem
Title: Knock-in mutation reveals an essential role for focal adhesion kinase activity in blood vessel morphogenesis and cell motility-polarity but not cell proliferation.
Volume: 285
Issue: 28
Pages: 21526-36
Strain
Attribute String: congenic, targeted mutation, transgenic
Publication
First Author: Lloyd SA
Year: 2012
Journal: J Bone Miner Res
Title: Connexin 43 deficiency attenuates loss of trabecular bone and prevents suppression of cortical bone formation during unloading.
Volume: 27
Issue: 11
Pages: 2359-72
Publication  
First Author: Foster BM
Year: 2022
Journal: Front Oncol
Title: Bone Marrow-Derived Stem Cell Factor Regulates Prostate Cancer-Induced Shifts in Pre-Metastatic Niche Composition.
Volume: 12
Pages: 855188
Publication  
First Author: Buck HV
Year: 2024
Journal: Biochem Biophys Res Commun
Title: Nitric oxide contributes to rapid sclerostin protein loss following mechanical load.
Volume: 727
Pages: 150315
Publication
First Author: Lim WH
Year: 2014
Journal: J Bone Miner Res
Title: Wnt signaling regulates pulp volume and dentin thickness.
Volume: 29
Issue: 4
Pages: 892-901
Publication  
First Author: Yang C
Year: 2020
Journal: Biomed Res Int
Title: Mesenchymal Stem Cell-Specific and Preosteoblast-Specific Ablation of TSC1 in Mice Lead to Severe and Slight Spinal Dysplasia, Respectively.
Volume: 2020
Pages: 4572687
Publication
First Author: Zanotti S
Year: 2013
Journal: J Biol Chem
Title: Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice.
Volume: 288
Issue: 30
Pages: 21547-57
Publication  
First Author: Huang B
Year: 2016
Journal: Nat Commun
Title: Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone.
Volume: 7
Pages: 13885
Publication    
First Author: Sun W
Year: 2019
Journal: Elife
Title: The mechanosensitive Piezo1 channel is required for bone formation.
Volume: 8
Publication  
First Author: St-Arnaud R
Year: 2022
Journal: Int J Mol Sci
Title: NACA and LRP6 Are Part of a Common Genetic Pathway Necessary for Full Anabolic Response to Intermittent PTH.
Volume: 23
Issue: 2
Publication
First Author: Lloyd SA
Year: 2013
Journal: Bone
Title: Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling.
Volume: 57
Issue: 1
Pages: 76-83
Publication
First Author: Zhao G
Year: 2020
Journal: J Bone Miner Res
Title: CCN1/Cyr61 Is Required in Osteoblasts for Responsiveness to the Anabolic Activity of PTH.
Volume: 35
Issue: 11
Pages: 2289-2300
Publication  
First Author: Droscha CJ
Year: 2017
Journal: Bone
Title: Osteoblast-specific deletion of Hrpt2/Cdc73 results in high bone mass and increased bone turnover.
Volume: 98
Pages: 68-78